Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
SVT-18651 by Laboratorios Salvat for Dermatitis (Eczema): Likelihood of Approval
SVT-18651 is under clinical development by Laboratorios Salvat and currently in Phase II for Dermatitis (Eczema). According to GlobalData, Phase...